MARKET

NTEC

NTEC

Intec Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.230
+0.350
+9.02%
Pre Market: 4.490 +0.26 +6.15% 06:26 06/15 EDT
OPEN
3.890
PREV CLOSE
3.880
HIGH
4.400
LOW
3.880
VOLUME
5.17K
TURNOVER
--
52 WEEK HIGH
15.82
52 WEEK LOW
2.200
MARKET CAP
20.40M
P/E (TTM)
-10.2795
1D
5D
1M
3M
1Y
5Y
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels
PALM BEACH,  Fla., /PRNewswire/ --  The recent pandemic has, as we all know, negatively affected almost every business and financial markets across the globe… and even the seemingly ever increasing Cannabidiol markets. The global COVID-19 pandemic outbrea...
PR Newswire - PRF · 6d ago
BNGO, CLNE, MVIS and CLOV among notable premarket gainers
Ra Medical Systems (RMED) +56%.Liminal BioSciences (LMNL) +42%.NextDecade Corporation (NEXT) +30%.U.S. Concrete (USCR) +28% as Vulcan Materials buys the Company in $1.3B deal.QTS Realty Trust (QTS) +20% on being acquired by Blackstone
Seekingalpha · 06/07 12:23
A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies (Updated)
As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.
Benzinga · 05/27 14:36
A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies
As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.
Benzinga · 05/14 18:21
United Microelectronics, Lumentum Holdings among premarket losers' pack
Array Technologies (ARRY) -28% on Q1 earnings release.CuriosityStream (CURI) -13% on Q1 earnings release.Grocery Outlet Holding (GO) -12% on Q1 earnings release.Lumentum Holdings (LITE) -8% on FQ3 earnings release.Intec Pharma (NTEC) -7%.Lemonade (LMND) -7...
Seekingalpha · 05/12 12:10
26 Stocks Moving in Wednesday's Pre-Market Session
Gainers Biomerica, Inc. (NASDAQ: BMRA) shares rose 30.8% to $4.46 in pre-market trading. Biomerica recently said its COVID-19 antigen rapid test can be performed with a nasal swab.
Benzinga · 05/12 10:10
Thinking about buying stock in Intec Pharma, Energous Corp, International Game Technology, 3D Systems, or Precipio?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NTEC, WATT, IGT, DDD, and PRPO.
PR Newswire - PRF · 05/11 12:30
DDD, IGT, EFC and FF among notable premarket movers
Intec Pharma (NTEC) +25%.Ferro Corporation (FOE) +23% on Q1 results.Cerecor (CERC) +15% as FDA grants fast track designation to its CERC-002.FutureFuel Corp. (FF) +14% on special dividend.Larimar Therapeutics (LRMR) +13% on Q1 results.Advanced Emissions
Seekingalpha · 05/11 12:18
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NTEC. Analyze the recent business situations of Intec Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NTEC stock price target is 13.00 with a high estimate of 13.00 and a low estimate of 13.00.
EPS
Institutional Holdings
Institutions: 59
Institutional Holdings: 10.48M
% Owned: 217.29%
Shares Outstanding: 4.82M
TypeInstitutionsShares
Increased
4
422.16K
New
5
85.84K
Decreased
4
157.59K
Sold Out
6
162.39K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.10%
Pharmaceuticals & Medical Research
+0.13%
Key Executives
Chairman/Director
John Kozarich
Chief Executive Officer/Vice Chairman/Director
Jeffrey Meckler
Chief Financial Officer
Nir Sassi
Chief Operating Officer
Nadav Navon
Chief Administrative Officer
Walt Linscott
Vice President
Liat Flaishon
Other
R. Michael Gendreau
Director
William Hayes
Director
Roger Pomerantz
No Data
About NTEC
Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs. The Company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson’s disease patients. Its pipeline also comprises The Accordion Pill-Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Furthermore under research is Accordion Pill-Undisclosed Drug for the prevention and treatment of small bowel non-steroidal anti-inflammatory drug (NSAID) induced ulcers.

Webull offers kinds of Intec Pharma Ltd stock information, including NASDAQ:NTEC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTEC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NTEC stock methods without spending real money on the virtual paper trading platform.